GlassScriptPhysician profile
Bic N Cung
NPI 1346476462
$3,301.69
in general payments reported to CMS, 2019-2025
32 companies · $1,223 in 2025
The $1,223 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $149 · 2022: $400 · 2023: $446 · 2024: $584 · 2025: $1,223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,252.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $398.43 | 2022-2025 | Jelmyto |
| Astellas Pharma US INC | $305.63 | 2019-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $296.44 | 2020-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $248.14 | 2019-2025 | |
| Immunitybio, INC. | $167.62 | 2024-2025 | |
| Pfizer INC. | $151.99 | 2019-2025 | |
| Abbvie INC. | $146.25 | 2019-2024 | |
| Axonics, INC. | $145.39 | 2022-2024 | Axonics, Bulkamid |
| Bioprotect Medical, INC. | $143.83 | 2025 | Bioprotect Balloon Implant System |
| Sumitomo Pharma America, INC. | $141.00 | 2023-2025 | Gemtesa |
| Ferring Pharmaceuticals INC. | $121.94 | 2023-2025 | Adstiladrin |
| Endo Pharmaceuticals INC. | $99.33 | 2019-2022 | |
| Baxter Healthcare | $94.53 | 2024 | Tisseel |
| Janssen Biotech, INC. | $94.20 | 2019-2025 | Erleada |
| Neotract INC. | $94.15 | 2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $77.40 | 2023-2025 | Itind System, Tecoflex |
| Merck Sharp & Dohme LLC | $77.24 | 2024-2025 | Keytruda, Keytruda Qlex |
| Coloplast Corp | $67.66 | 2023 | Titan |
| Novartis Pharmaceuticals Corporation | $53.08 | 2025 | |
| Philips North America LLC | $50.21 | 2025 | Disease Management Solutions Equipment Undivided |
| Palette Life Sciences, INC. | $47.53 | 2022 | |
| Myovant Sciences INC. | $38.33 | 2022 | |
| Boston Scientific Corporation | $36.02 | 2025 | Ams 800 Artificial Urinary Sphincter |
| Antares Pharma, INC. | $30.66 | 2019 | |
| Blue Earth Diagnostics | $26.30 | 2024 | |
| Progenics Pharmaceuticals, INC. | $26.20 | 2024 | |
| Teleflex LLC | $24.25 | 2025 | Urolift |
| Janssen Pharmaceuticals, INC | $23.68 | 2025 | Erleada |
| Accord Healthcare, INC. | $21.68 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $20.83 | 2020 | |
| Koelis INC. | $16.38 | 2023 | |
| Sagent Pharmaceuticals | $15.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bic Cung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.